Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3K14 acetyltransferase activity	BRPF3 JADE1 BRD1	6.31e-05	9	185	3	GO:0036408
GeneOntologyMolecularFunction	histone H4K8 acetyltransferase activity	BRPF3 JADE1 BRD1	1.22e-04	11	185	3	GO:0043996
GeneOntologyMolecularFunction	histone H4K5 acetyltransferase activity	BRPF3 JADE1 BRD1	1.22e-04	11	185	3	GO:0043995
GeneOntologyMolecularFunction	histone H4K12 acetyltransferase activity	BRPF3 JADE1 BRD1	1.62e-04	12	185	3	GO:0043997
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DOCK4 GAPVD1 ARHGEF11 SLIT2 EIF2B2 ELMOD3 RASA4B SGSM3 ARHGEF37 HERC1 ALS2 RGS3 RASA4 ARHGAP45	2.81e-04	507	185	14	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DOCK4 GAPVD1 ARHGEF11 SLIT2 EIF2B2 ELMOD3 RASA4B SGSM3 ARHGEF37 HERC1 ALS2 RGS3 RASA4 ARHGAP45	2.81e-04	507	185	14	GO:0030695
GeneOntologyMolecularFunction	GTPase activator activity	DOCK4 GAPVD1 ARHGEF11 ELMOD3 RASA4B SGSM3 ALS2 RGS3 RASA4 ARHGAP45	2.86e-04	279	185	10	GO:0005096
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	BRPF3 JADE1 BRD1	3.28e-04	15	185	3	GO:0010484
GeneOntologyMolecularFunction	epidermal growth factor receptor activity	ERBB4 EGFR	5.06e-04	4	185	2	GO:0005006
GeneOntologyMolecularFunction	glycerol-3-phosphate O-acyltransferase activity	GPAT2 GPAM	8.38e-04	5	185	2	GO:0004366
GeneOntologyCellularComponent	centriole	DZIP1L STARD9 ODAD3 TEDC2 RTTN CEP135 CEP83 CEP295 PCNT	3.00e-05	172	191	9	GO:0005814
Domain	L_dom-like	PODNL1 ERBB4 FBXL8 LRSAM1 LGR4 LRRIQ4 SLIT2 LRRC26 PKD1 ZER1 LRFN1 NLRX1 EGFR LRRN4	3.75e-06	328	180	14	IPR032675
Domain	LRR_8	PODNL1 LRSAM1 LGR4 LRRIQ4 SLIT2 LRRC26 PKD1 LRFN1 LRRN4	4.29e-05	171	180	9	PF13855
Domain	EPL1	BRPF3 JADE1 BRD1	4.76e-05	8	180	3	PF10513
Domain	Enhancer_polycomb-like_N	BRPF3 JADE1 BRD1	4.76e-05	8	180	3	IPR019542
Domain	LRR_TYP	PODNL1 LRSAM1 LGR4 LRRIQ4 SLIT2 LRRC26 PKD1 LRFN1 LRRN4	5.61e-05	177	180	9	SM00369
Domain	Leu-rich_rpt_typical-subtyp	PODNL1 LRSAM1 LGR4 LRRIQ4 SLIT2 LRRC26 PKD1 LRFN1 LRRN4	5.61e-05	177	180	9	IPR003591
Domain	-	PODNL1 FBXL8 LRSAM1 LGR4 LRRIQ4 SLIT2 LRRC26 PKD1 ZER1 LRFN1 NLRX1 LRRN4	6.84e-05	321	180	12	3.80.10.10
Domain	BCL9	BCL9L BCL9	9.24e-05	2	180	2	PF11502
Domain	Bcl-9	BCL9L BCL9	9.24e-05	2	180	2	IPR015668
Domain	BCL9_beta-catenin-bd_dom	BCL9L BCL9	9.24e-05	2	180	2	IPR024670
Domain	Spectrin_repeat	ACTN4 ACTN3 SPTBN5 PPL	1.64e-04	29	180	4	IPR002017
Domain	SPEC	ACTN4 ACTN3 SPTBN5 PPL	2.43e-04	32	180	4	SM00150
Domain	Spectrin/alpha-actinin	ACTN4 ACTN3 SPTBN5 PPL	2.43e-04	32	180	4	IPR018159
Domain	-	RASA4B RASA4	2.75e-04	3	180	2	4.10.1130.10
Domain	GPAT/DHAPAT	GPAT2 GPAM	2.75e-04	3	180	2	IPR022284
Domain	ARM-like	USP9Y NBEAL2 AP1G2 ZER1 RTTN APC HEATR5A ARVCF WDFY3 STAG3	2.99e-04	270	180	10	IPR011989
Domain	Leu-rich_rpt	PODNL1 LRSAM1 LGR4 LRRIQ4 SLIT2 LRRC26 PKD1 LRFN1 NLRX1 LRRN4	3.08e-04	271	180	10	IPR001611
Domain	RasGAP	GAPVD1 RASA4B RASA4	3.68e-04	15	180	3	PF00616
Domain	RAS_GTPASE_ACTIV_1	GAPVD1 RASA4B RASA4	3.68e-04	15	180	3	PS00509
Domain	RAS_GTPASE_ACTIV_2	GAPVD1 RASA4B RASA4	3.68e-04	15	180	3	PS50018
Domain	CH	ACTN4 ACTN3 SPTBN5 NAV2 MICAL2	4.07e-04	65	180	5	SM00033
Domain	-	GAPVD1 RASA4B RASA4	4.49e-04	16	180	3	1.10.506.10
Domain	ARM-type_fold	USP34 USP9Y NBEAL2 AP1G2 ZER1 RTTN APC HEATR5A ARVCF WDFY3 STAG3	4.63e-04	339	180	11	IPR016024
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB4 EGFR	5.47e-04	4	180	2	IPR016245
Domain	CH	ACTN4 ACTN3 SPTBN5 NAV2 MICAL2	5.74e-04	70	180	5	PF00307
Domain	-	ACTN4 ACTN3 SPTBN5 NAV2 MICAL2	6.12e-04	71	180	5	1.10.418.10
Domain	RasGAP_dom	GAPVD1 RASA4B RASA4	6.46e-04	18	180	3	IPR001936
Domain	CH	ACTN4 ACTN3 SPTBN5 NAV2 MICAL2	6.96e-04	73	180	5	PS50021
Domain	CH-domain	ACTN4 ACTN3 SPTBN5 NAV2 MICAL2	7.87e-04	75	180	5	IPR001715
Domain	DUF4704	NBEAL2 WDFY3	9.06e-04	5	180	2	IPR031570
Domain	DUF4704	NBEAL2 WDFY3	9.06e-04	5	180	2	PF15787
Domain	EPHD	BRPF3 JADE1 BRD1	1.18e-03	22	180	3	PS51805
Domain	PH_BEACH	NBEAL2 WDFY3	1.35e-03	6	180	2	PF14844
Domain	GF_recep_IV	ERBB4 EGFR	1.35e-03	6	180	2	PF14843
Domain	GF_recep_IV	ERBB4 EGFR	1.35e-03	6	180	2	IPR032778
Domain	EFhand_Ca_insen	ACTN4 ACTN3	1.35e-03	6	180	2	PF08726
Domain	EF-hand_Ca_insen	ACTN4 ACTN3	1.35e-03	6	180	2	IPR014837
Domain	Spectrin	ACTN4 ACTN3 SPTBN5	1.35e-03	23	180	3	PF00435
Domain	ACTININ_2	ACTN4 ACTN3 SPTBN5	1.35e-03	23	180	3	PS00020
Domain	ACTININ_1	ACTN4 ACTN3 SPTBN5	1.35e-03	23	180	3	PS00019
Domain	Actinin_actin-bd_CS	ACTN4 ACTN3 SPTBN5	1.35e-03	23	180	3	IPR001589
Domain	-	AP1G2 ZER1 RTTN APC HEATR5A ARVCF WDFY3 STAG3	1.43e-03	222	180	8	1.25.10.10
Domain	Cys-rich_flank_reg_C	SLIT2 LRRC26 PKD1 LRFN1 LRRN4	1.78e-03	90	180	5	IPR000483
Domain	LRRCT	SLIT2 LRRC26 PKD1 LRFN1 LRRN4	1.78e-03	90	180	5	SM00082
Domain	Recep_L_domain	ERBB4 EGFR	1.88e-03	7	180	2	PF01030
Domain	Furin-like	ERBB4 EGFR	1.88e-03	7	180	2	PF00757
Domain	Rcpt_L-dom	ERBB4 EGFR	1.88e-03	7	180	2	IPR000494
Domain	Furin-like_Cys-rich_dom	ERBB4 EGFR	1.88e-03	7	180	2	IPR006211
Domain	-	ERBB4 EGFR	1.88e-03	7	180	2	3.80.20.20
Domain	PH-BEACH_dom	NBEAL2 WDFY3	2.49e-03	8	180	2	IPR023362
Domain	-	NBEAL2 WDFY3	2.49e-03	8	180	2	2.30.29.40
Domain	PH_BEACH	NBEAL2 WDFY3	2.49e-03	8	180	2	PS51783
Domain	LRRNT	PODNL1 LGR4 SLIT2 LRRC26 PKD1	2.59e-03	98	180	5	IPR000372
Domain	LRRNT	PODNL1 LGR4 SLIT2 LRRC26 PKD1	2.59e-03	98	180	5	SM00013
Domain	PH_dom-like	ARHGEF11 SPTBN5 NBEAL2 OSBPL5 RASA4B PHLDB3 ALS2 RGS3 RASA4 OSBPL3 WDFY3	2.88e-03	426	180	11	IPR011993
Domain	BTK	RASA4B RASA4	3.18e-03	9	180	2	SM00107
Domain	BEACH	NBEAL2 WDFY3	3.18e-03	9	180	2	PS50197
Domain	Beach	NBEAL2 WDFY3	3.18e-03	9	180	2	PF02138
Domain	-	NBEAL2 WDFY3	3.18e-03	9	180	2	1.10.1540.10
Domain	Beach	NBEAL2 WDFY3	3.18e-03	9	180	2	SM01026
Domain	Znf_Btk_motif	RASA4B RASA4	3.18e-03	9	180	2	IPR001562
Domain	BEACH_dom	NBEAL2 WDFY3	3.18e-03	9	180	2	IPR000409
Domain	BTK	RASA4B RASA4	3.18e-03	9	180	2	PF00779
Domain	ZF_BTK	RASA4B RASA4	3.18e-03	9	180	2	PS51113
Domain	ATP_grasp_subdomain_2	TTLL5 CARNS1 GSS	3.24e-03	31	180	3	IPR013816
Domain	LRR	PODNL1 LRSAM1 LGR4 LRRIQ4 SLIT2 PKD1 LRFN1	3.40e-03	201	180	7	PS51450
Domain	Zinc_finger_PHD-type_CS	BRPF3 JADE1 BRD1 AIRE	3.57e-03	65	180	4	IPR019786
Domain	Leu-rich_rpt_4	PODNL1 LRRIQ4	3.95e-03	10	180	2	IPR025875
Domain	VPS9	GAPVD1 ALS2	3.95e-03	10	180	2	PS51205
Domain	LRR_4	PODNL1 LRRIQ4	3.95e-03	10	180	2	PF12799
Domain	VPS9	GAPVD1 ALS2	3.95e-03	10	180	2	PF02204
Domain	VPS9	GAPVD1 ALS2	3.95e-03	10	180	2	IPR003123
Domain	RGS	ARHGEF11 RGS3 SNX14	4.59e-03	35	180	3	SM00315
Domain	RGS	ARHGEF11 RGS3 SNX14	4.98e-03	36	180	3	PS50132
Domain	LRR_1	PODNL1 LRSAM1 LGR4 LRRIQ4 SLIT2 LRRC26 LRRN4	5.42e-03	219	180	7	PF00560
Domain	PH	ARHGEF11 SPTBN5 OSBPL5 RASA4B PHLDB3 ALS2 RASA4 OSBPL3	5.64e-03	278	180	8	SM00233
Domain	Oxysterol-bd_CS	OSBPL5 OSBPL3	5.72e-03	12	180	2	IPR018494
Domain	Oxysterol_BP	OSBPL5 OSBPL3	5.72e-03	12	180	2	PF01237
Domain	Oxysterol-bd	OSBPL5 OSBPL3	5.72e-03	12	180	2	IPR000648
Domain	OSBP	OSBPL5 OSBPL3	5.72e-03	12	180	2	PS01013
Domain	PH_DOMAIN	ARHGEF11 SPTBN5 OSBPL5 RASA4B PHLDB3 ALS2 RASA4 OSBPL3	5.76e-03	279	180	8	PS50003
Domain	PH_domain	ARHGEF11 SPTBN5 OSBPL5 RASA4B PHLDB3 ALS2 RASA4 OSBPL3	5.89e-03	280	180	8	IPR001849
Domain	PHD	BRPF3 JADE1 BRD1 AIRE	5.96e-03	75	180	4	PF00628
Domain	RGS	ARHGEF11 RGS3 SNX14	6.24e-03	39	180	3	IPR016137
Domain	ARM_REPEAT	ZER1 APC ARVCF	6.69e-03	40	180	3	PS50176
Domain	ARM	ZER1 APC ARVCF	6.69e-03	40	180	3	SM00185
Domain	Znf_PHD-finger	BRPF3 JADE1 BRD1 AIRE	7.15e-03	79	180	4	IPR019787
Domain	Kinesin_motor_CS	KIF12 STARD9 KIF16B	7.17e-03	41	180	3	IPR019821
Domain	RasGAP	RASA4B RASA4	7.79e-03	14	180	2	SM00323
Domain	RasGAP_CS	RASA4B RASA4	7.79e-03	14	180	2	IPR023152
Domain	-	KIF12 STARD9 KIF16B	8.73e-03	44	180	3	3.40.850.10
Domain	Kinesin	KIF12 STARD9 KIF16B	8.73e-03	44	180	3	PF00225
Domain	KISc	KIF12 STARD9 KIF16B	8.73e-03	44	180	3	SM00129
Domain	KINESIN_MOTOR_1	KIF12 STARD9 KIF16B	8.73e-03	44	180	3	PS00411
Domain	Kinesin_motor_dom	KIF12 STARD9 KIF16B	8.73e-03	44	180	3	IPR001752
Domain	KINESIN_MOTOR_2	KIF12 STARD9 KIF16B	8.73e-03	44	180	3	PS50067
Domain	SH3_2	DOCK4 MYO15B CASKIN2 ARHGEF37	9.60e-03	86	180	4	PF07653
Domain	SH3_2	DOCK4 MYO15B CASKIN2 ARHGEF37	9.60e-03	86	180	4	IPR011511
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRNP1 USP34 VWA8 PIEZO1 IRAK1 JADE1 BCL9 ARHGEF11 TAOK2 TLK1 NBEAL2 OSBPL5 PKD1 NAV2 AP1G2 ZER1 ULK1 HERC1 ABTB2 PHLDB3 LRFN1 SLC37A3 NLRX1 RTTN HECTD4 CHSY1 CCDC142 INTS5 RPAP1 ARVCF NINL WDFY3 VAMP8 PCNT	5.26e-16	1105	194	34	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 BRPF3 GAPVD1 VWA8 PIEZO1 JADE1 NUP205 TAOK2 CASKIN2 AMOT NBEAL2 OSBPL5 NAV2 CARNS1 HECTD4 KIF16B CHSY1 URGCP INTS5 NINL LZTS2	2.79e-12	529	194	21	14621295
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	USP34 TLK1 AMOT NAV2 TTC28 OBSL1 ALS2 ABLIM1 TENM4 WDFY3 PCNT	6.35e-08	225	194	11	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 STARD9 ULK1 TTC28 OBSL1 ALS2 HEATR5A ABLIM1 TENM4 RPAP1 PDE4DIP CCAR2 AQR PCNT	8.16e-08	407	194	14	12693553
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 TTLL5 LRSAM1 ACTN4 USP9Y PKD1 SGSM3 MVP ABHD14A OXR1 TTC28 HECTD4 OBSL1 APC AIRE JAKMIP3 PRPF8 DALRD3 TXNDC11 ABLIM1 MICAL2 PDE4DIP WDFY3 PCNT	2.47e-07	1285	194	24	35914814
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	GAPVD1 MYO5B SLC35E1 ACTN4 COPS2 NUP205 SLIT2 RNF214 TLK1 AMOT EIF2B2 PHLDB3 LRFN1 OBSL1 PRPF8 URGCP TAF6L ABLIM1 OXA1L OSBPL3 TTC21B NINL CCAR2	1.49e-06	1321	194	23	27173435
Pubmed	Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.	BCL9L BCL9 APC	1.69e-06	5	194	3	30760710
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	GAPVD1 IRAK1 CASKIN2 AMOT FAM135A TTC28 APC ABLIM1 LZTS2 VAMP8	2.50e-06	263	194	10	34702444
Pubmed	Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer.	BCL9L BCL9 APC	3.38e-06	6	194	3	30760720
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ORC3 SLC35E1 CASKIN2 ULK1 RNF31 TTC28 OBSL1 APC GPAM RGS3 URGCP RPAP1 ARVCF OSBPL3 AQR	4.24e-06	650	194	15	38777146
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	GAPVD1 LRSAM1 USP9Y ARHGEF11 COPS2 NBEAL2 NAV2 HERC1 NWD1 PRPF8 SNX14 VPS13D HYDIN	4.99e-06	497	194	13	36774506
Pubmed	Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation.	CHGA TRPM5 HHIP EGFR MAPK3	6.50e-06	47	194	5	32747435
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	MYO5B VWA8 ARHGEF11 TAOK2 CARNS1 TTC28 VPS13D	8.93e-06	130	194	7	12421765
Pubmed	Comparative genome mapping in the sequence-based era: early experience with human chromosome 7.	DOCK4 RASA4B RASA4	9.38e-06	8	194	3	10810084
Pubmed	ERBB3-dependent AKT and ERK pathways are essential for atrioventricular cushion development in mouse embryos.	ERBB4 EGFR MAPK3	1.40e-05	9	194	3	34714866
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	BRPF3 ARHGEF11 OSBPL5 PKD1 RAG1 CACNA1F AIRE TRIM39 CD93 CHRD	1.77e-05	329	194	10	17474147
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	GAPVD1 GAL3ST2 NUP205 MYO15B AMOT PKD1 CACNA1F MAGEE2 GPAM PRPF8 TAF6L RPAP1 CHRD CEP295 CFAP44	1.84e-05	736	194	15	29676528
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	STARD9 NAV2 CARNS1 FAM135A HEATR5A TENM4 RPAP1	2.57e-05	153	194	7	10718198
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	USP34 VWA8 NBEAL2 PPL RASA4 AQR	2.84e-05	105	194	6	9628581
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 KNTC1 USP34 LRSAM1 ZCCHC2 STAT2 FAM135A TTC28 OBSL1 APC LZTS2 CFAP44 PCNT	2.93e-05	588	194	13	38580884
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 GAPVD1 ERBB4 CASKIN2 AMOT STARD9 NAV2 BRD1 ABTB2 TTC28 APC ALS2 ABLIM1 VPS13D OSBPL3 AQR	2.95e-05	861	194	16	36931259
Pubmed	Identification of a new glycerol-3-phosphate acyltransferase isoenzyme, mtGPAT2, in mitochondria.	GPAT2 GPAM	3.10e-05	2	194	2	14724270
Pubmed	Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins.	ARHGEF11 SLC1A6	3.10e-05	2	194	2	11242047
Pubmed	Lgr4-mediated Wnt/β-catenin signaling in peritubular myoid cells is essential for spermatogenesis.	LGR4 APC	3.10e-05	2	194	2	23533175
Pubmed	Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.	BCL9L BCL9	3.10e-05	2	194	2	15371335
Pubmed	Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women.	CEP295 PCNT	3.10e-05	2	194	2	34418690
Pubmed	Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.	ERBB4 PKD1	3.10e-05	2	194	2	28077374
Pubmed	Autosomal dominant retinitis pigmentosa-associated gene PRPF8 is essential for hypoxia-induced mitophagy through regulating ULK1 mRNA splicing.	ULK1 PRPF8	3.10e-05	2	194	2	30103670
Pubmed	Autoimmunity, Not a Developmental Defect, is the Cause for Subfertility of Autoimmune Regulator (Aire) Deficient Mice.	RAG1 AIRE	3.10e-05	2	194	2	25689230
Pubmed	EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators.	APC EGFR	3.10e-05	2	194	2	21653642
Pubmed	T-cell receptor repertoire analysis of CD4-positive T cells from blood and an affected organ in an autoimmune mouse model.	RAG1 AIRE	3.10e-05	2	194	2	37909727
Pubmed	Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.	BCL9L BCL9	3.10e-05	2	194	2	38811552
Pubmed	NLRX1 Acts as an Epithelial-Intrinsic Tumor Suppressor through the Modulation of TNF-Mediated Proliferation.	NLRX1 APC	3.10e-05	2	194	2	26971996
Pubmed	The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.	NLRX1 APC	3.10e-05	2	194	2	26971998
Pubmed	Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.	ERBB4 EGFR	3.10e-05	2	194	2	23927961
Pubmed	Lymphopenia-induced proliferation in the absence of functional Autoimmune regulator (Aire) induces colitis in mice.	RAG1 AIRE	3.10e-05	2	194	2	26112418
Pubmed	CISH controls bacterial burden early after infection with Mycobacterium tuberculosis in mice.	CISH RAG1	3.10e-05	2	194	2	29050767
Pubmed	Transactivated Epidermal Growth Factor Receptor Recruitment of α-actinin-4 From F-actin Contributes to Invasion of Brain Microvascular Endothelial Cells by Meningitic Escherichia coli.	ACTN4 EGFR	3.10e-05	2	194	2	30687645
Pubmed	Cooperative activation of transcription by autoimmune regulator AIRE and CBP.	AIRE TAF6L	3.10e-05	2	194	2	15964547
Pubmed	The Globular C1q Receptor Is Required for Epidermal Growth Factor Receptor Signaling during Candida albicans Infection.	CD93 EGFR	3.10e-05	2	194	2	34724825
Pubmed	MAPK3 deficiency drives autoimmunity via DC arming.	RAG1 MAPK3	3.10e-05	2	194	2	20186879
Pubmed	Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus.	RAG1 CXCR3	3.10e-05	2	194	2	19620294
Pubmed	GPR48 regulates epithelial cell proliferation and migration by activating EGFR during eyelid development.	LGR4 EGFR	3.10e-05	2	194	2	18487371
Pubmed	Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.	CD93 MMRN2	3.10e-05	2	194	2	28912033
Pubmed	CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.	RAG1 CXCR3	3.10e-05	2	194	2	24390137
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4B RASA4	3.10e-05	2	194	2	11448776
Pubmed	Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cells.	RAG1 APC	3.10e-05	2	194	2	25228656
Pubmed	Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation.	RAG1 CXCR3	3.10e-05	2	194	2	28129932
Pubmed	Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.	ERBB4 EGFR	3.10e-05	2	194	2	24338375
Pubmed	STAT2 Controls Colorectal Tumorigenesis and Resistance to Anti-Cancer Drugs.	STAT2 APC	3.10e-05	2	194	2	38001683
Pubmed	Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.	ERBB4 EGFR	3.10e-05	2	194	2	25740878
Pubmed	Eye-open at birth phenotype with reduced keratinocyte motility in LGR4 null mice.	LGR4 EGFR	3.10e-05	2	194	2	17850793
Pubmed	BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.	BCL9L BCL9	3.10e-05	2	194	2	33767438
Pubmed	Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.	DEPTOR EGFR	3.10e-05	2	194	2	26896556
Pubmed	[Correlations of EGFR and LRP to chemotherapy resistance and prognosis of ovarian cancer].	MVP EGFR	3.10e-05	2	194	2	19080004
Pubmed	A Genome-Wide Association Study of a Korean Population Identifies Genetic Susceptibility to Hypertension Based on Sex-Specific Differences.	HECTD4 ACAD10	3.10e-05	2	194	2	34828409
Pubmed	Cancer regulator EGFR-ErbB4 heterodimer is stabilized through glycans at the dimeric interface.	ERBB4 EGFR	3.10e-05	2	194	2	36427180
Pubmed	erbB-1 and erbB-4 receptors act in concert to facilitate female sexual development and mature reproductive function.	ERBB4 EGFR	3.10e-05	2	194	2	15591145
Pubmed	The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte.	RAG1 MAPK3	3.10e-05	2	194	2	8706129
Pubmed	Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.	BCL9L BCL9	3.10e-05	2	194	2	20682801
Pubmed	An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.	RASA4B RASA4	3.10e-05	2	194	2	16041389
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 GAPVD1 DZIP1L LGR4 ACTN4 JADE1 ZCCHC2 COPS2 MEST AMOT HERC1 FAM135A APC ALS2 OSBPL3 CEP295 CCDC171 PCNT	4.06e-05	1084	194	18	11544199
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	KNTC1 BCL9L GAPVD1 AMOT TTC28 APC ABLIM1 VIPAS39 NINL CEP295 LZTS2	4.60e-05	446	194	11	24255178
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	CHGA SLIT2 TTC28 RTTN PPL CEP83 HYDIN	5.04e-05	170	194	7	23314748
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	PIEZO1 BCL9 COPS2 TAOK2 MEST RNF214 PKD1 KCTD7 ABHD14A SLC37A3 RNF31 DALRD3 TXNDC11 ZIC5 FER1L4 MFSD8 LZTS2 ARHGAP45 CFAP46	5.51e-05	1215	194	19	15146197
Pubmed	Sequence and expression of murine type I hair keratins mHa2 and mHa3.	KIF12 STARD9 KIF16B	5.95e-05	14	194	3	7514534
Pubmed	Mechanical regulation of glycolysis via cytoskeleton architecture.	VWA8 ACTN4 CCAR2	5.95e-05	14	194	3	32051585
Pubmed	CEP44 ensures the formation of bona fide centriole wall, a requirement for the centriole-to-centrosome conversion.	CEP135 CEP295 PCNT	5.95e-05	14	194	3	32060285
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	KNTC1 USP34 GAPVD1 SLC35E1 STAT2 PHLDB3 TTC28 APC ABLIM1 VIPAS39 CEP135 CCAR2 CEP295 VAMP8	7.03e-05	733	194	14	34672954
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	SPTBN5 PKD1 RTTN OXA1L NINL CFAP44 PCNT	9.17e-05	187	194	7	26460568
Pubmed	Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors.	EGFR MAPK3	9.25e-05	3	194	2	19147502
Pubmed	Heparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cells.	ERBB4 EGFR	9.25e-05	3	194	2	15562026
Pubmed	GPR48-Induced keratinocyte proliferation occurs through HB-EGF mediated EGFR transactivation.	LGR4 EGFR	9.25e-05	3	194	2	20732323
Pubmed	ErbB1 and ErbB4 generate opposing signals regulating mesenchymal cell proliferation during valvulogenesis.	ERBB4 EGFR	9.25e-05	3	194	2	28232522
Pubmed	Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.	EGFR MAPK3	9.25e-05	3	194	2	24966948
Pubmed	The trans-Golgi proteins SCLIP and SCG10 interact with chromogranin A to regulate neuroendocrine secretion.	CHGA STMN3	9.25e-05	3	194	2	18549247
Pubmed	Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors.	CXCR3 PRLHR	9.25e-05	3	194	2	8666380
Pubmed	CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.	CD93 MMRN2	9.25e-05	3	194	2	29763414
Pubmed	Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium.	ERBB4 EGFR	9.25e-05	3	194	2	27285994
Pubmed	Changes in the expression and cytological localization of betacellulin and its receptors (ErbB-1 and ErbB-4) in the trophoblasts in human placenta over the course of pregnancy.	ERBB4 EGFR	9.25e-05	3	194	2	15248827
Pubmed	Lipid mediator Leukotriene D4-induces airway epithelial cells proliferation through EGFR/ERK1/2 pathway.	EGFR MAPK3	9.25e-05	3	194	2	29751150
Pubmed	Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells.	APC EGFR	9.25e-05	3	194	2	23457600
Pubmed	Epidermal growth factor receptor and podocin predict nephropathy progression in type 2 diabetic patients through interaction with the autophagy influencer ULK-1.	ULK1 EGFR	9.25e-05	3	194	2	30545560
Pubmed	MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation.	EGFR MAPK3	9.25e-05	3	194	2	22021337
Pubmed	Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands.	EGFR MAPK3	9.25e-05	3	194	2	20664595
Pubmed	Differential regulation of β-catenin-mediated transcription via N- and C-terminal co-factors governs identity of murine intestinal epithelial stem cells.	BCL9L BCL9	9.25e-05	3	194	2	33649334
Pubmed	Oxysterol binding protein induces upregulation of SREBP-1c and enhances hepatic lipogenesis.	OSBPL5 OSBPL3	9.25e-05	3	194	2	17303778
Pubmed	Epiregulin promotes hair growth via EGFR-medicated epidermal and ErbB4-mediated dermal stimulation.	ERBB4 EGFR	9.25e-05	3	194	2	32700456
Pubmed	Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.	APC EGFR	9.25e-05	3	194	2	11818567
Pubmed	Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming.	RAG1 APC	9.25e-05	3	194	2	21303980
Pubmed	The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta.	FADD IRAK1	9.25e-05	3	194	2	11828002
Pubmed	Aire deficiency promotes TRP-1-specific immune rejection of melanoma.	RAG1 AIRE	9.25e-05	3	194	2	23370329
Pubmed	Transfer of Functional Cargo in Exomeres.	APC EGFR	9.25e-05	3	194	2	30956133
Pubmed	Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma.	ERBB4 EGFR	9.25e-05	3	194	2	15026342
Pubmed	Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.	ERBB4 APC	9.25e-05	3	194	2	26527747
Pubmed	The protective effect of betacellulin against acute pancreatitis is ERBB4 dependent.	ERBB4 EGFR	9.25e-05	3	194	2	31456099
Pubmed	Inhibition of the EGF receptor and ERK1/2 signaling pathways rescues the human epidermoid carcinoma A431 cells from IFNγ-induced apoptosis.	EGFR MAPK3	9.25e-05	3	194	2	21606674
Pubmed	Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions.	ERBB4 EGFR	9.25e-05	3	194	2	18424286
Pubmed	HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.	PKD1 EGFR	9.25e-05	3	194	2	23152903
Pubmed	Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptors.	EGFR HRH4	9.25e-05	3	194	2	27180173
Interaction	TOP3B interactions	TRNP1 USP34 VWA8 PIEZO1 IRAK1 ACTN4 JADE1 BCL9 ARHGEF11 TAOK2 TLK1 NBEAL2 OSBPL5 PKD1 NAV2 AP1G2 ZER1 ULK1 HERC1 ABTB2 PHLDB3 LRFN1 SLC37A3 NLRX1 RTTN HECTD4 CHSY1 CCDC142 INTS5 RPAP1 ARVCF NINL WDFY3 VAMP8 PCNT	2.44e-07	1470	188	35	int:TOP3B
Interaction	KRT8 interactions	DOCK4 TTLL5 NUP205 PKD1 ZER1 RNF31 KIF16B OBSL1 APC PRPF8 PPL EGFR NINL MAPK3 LZTS2 PCNT	4.08e-06	441	188	16	int:KRT8
Interaction	BTC interactions	ERBB4 EIF2B2 TEDC2 APC EGFR	7.90e-06	30	188	5	int:BTC
Interaction	TBKBP1 interactions	IRAK1 RNF214 ANGPT4 OBSL1 EGFR CEP135 LZTS2	9.83e-06	80	188	7	int:TBKBP1
Interaction	BAG2 interactions	BRPF3 GAPVD1 IRAK1 RNF214 AMOT BRD1 KCTD7 RNF31 TEDC2 KIF16B OBSL1 PRPF8 URGCP VPS13D RPAP1 EGFR NINL CCAR2	2.24e-05	622	188	18	int:BAG2
Interaction	MIS18A interactions	AMOT TEDC2 CEP135 CEP83 NINL STX11 PCNT	3.25e-05	96	188	7	int:MIS18A
Interaction	EEF1AKMT3 interactions	KNTC1 USP34 GAPVD1 IRAK1 NBEAL2 AP1G2 HERC1 GPAT2 RNF31 RPAP1 OSBPL3 CCAR2 AQR	3.95e-05	364	188	13	int:EEF1AKMT3
GeneFamily	Actinins	ACTN4 ACTN3	2.77e-04	4	124	2	1112
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB4 EGFR	2.77e-04	4	124	2	1096
GeneFamily	Glycerol-3-phosphate acyltransferases	GPAT2 GPAM	2.77e-04	4	124	2	1035
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL2 WDFY3	1.63e-03	9	124	2	1230
GeneFamily	VPS9 domain containing	GAPVD1 ALS2	2.03e-03	10	124	2	928
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4B RASA4	2.03e-03	10	124	2	830
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBPL5 OSBPL3	2.94e-03	12	124	2	670
GeneFamily	PHD finger proteins	BRPF3 JADE1 BRD1 AIRE	3.42e-03	90	124	4	88
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF12 STARD9 KIF16B	3.86e-03	46	124	3	622
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	TRNP1 PDGFA MYO5B CCDC30 TTLL5 TAOK2 NAV2 AP1G2 CARNS1 MVP NLRX1 OBSL1 LAMA3 PPL HHIP INTS5 NRBP2 ARVCF P3H2 PDE4DIP NINL LRRN4 VAMP8 STX11	1.52e-07	955	192	24	M45680
Coexpression	GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	FBXL8 PIEZO1 ACTN4 RNF214 NBEAL2 CXCR3 PSTPIP1 RGS3 MICAL2 OSBPL3	2.27e-06	199	192	10	M3107
Coexpression	HALLMARK_MITOTIC_SPINDLE	DOCK4 KNTC1 ACTN4 ARHGEF11 TAOK2 TLK1 APC ALS2 PCNT	1.71e-05	199	192	9	M5893
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL	TRNP1 PDGFA MYO5B PIEZO1 TTLL5 NAV2 AP1G2 CARNS1 MVP OBSL1 LAMA3 PPL HHIP NRBP2 LRRN4 VAMP8 STX11	1.83e-05	704	192	17	M45672
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NAV2 DEPTOR OBSL1 LAMA3 HHIP TENM4 EGFR MICAL2 P3H2 VAMP8	6.03e-10	185	194	11	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B CCDC30 SAMD12 KIF12 LGR4 ABTB2 OXR1 ABLIM1 P3H2 NINL	9.45e-10	193	194	11	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B CCDC30 SAMD12 KIF12 LGR4 ABTB2 OXR1 ABLIM1 NINL HYDIN	9.98e-10	194	194	11	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B CCDC30 SAMD12 KIF12 LGR4 ABTB2 OXR1 ABLIM1 P3H2 NINL	9.98e-10	194	194	11	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B CCDC30 SAMD12 KIF12 LGR4 DEPTOR OXR1 ABLIM1 NINL HYDIN	1.11e-09	196	194	11	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NAV2 OBSL1 LAMA3 PPL HHIP TENM4 EGFR MICAL2 P3H2	8.79e-09	184	194	10	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 LGR4 MEST FAM135A ABTB2 DEPTOR CYP27C1 LAMA3 PPL OSBPL3	1.03e-08	187	194	10	77886f99c229610abd28c4c370d2c7d1536c9782
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 NAV2 FAM135A DEPTOR OXR1 ABLIM1 TENM4 OSBPL3	1.19e-08	190	194	10	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 NAV2 FAM135A DEPTOR OXR1 ABLIM1 TENM4 OSBPL3	1.19e-08	190	194	10	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 FAM135A DEPTOR OXR1 ABLIM1 TENM4 P3H2 OSBPL3	1.26e-08	191	194	10	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 NAV2 DEPTOR OXR1 ABLIM1 TENM4 P3H2 OSBPL3	1.26e-08	191	194	10	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 NAV2 DEPTOR OXR1 ABLIM1 TENM4 P3H2 OSBPL3	1.26e-08	191	194	10	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BICDL2 ERBB4 SAMD12 LGR4 DEPTOR OXR1 PPL ABLIM1 P3H2 OSBPL3	1.39e-08	193	194	10	263d185af6ed80e639f864e4966268e0862c61dc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BICDL2 ERBB4 SAMD12 LGR4 DEPTOR OXR1 PPL ABLIM1 P3H2 OSBPL3	1.39e-08	193	194	10	80e058c224749b5fe0ba3e944b48317c2371cb63
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BICDL2 ERBB4 SAMD12 LGR4 DEPTOR OXR1 PPL ABLIM1 P3H2 OSBPL3	1.39e-08	193	194	10	b991fbbb4618401624f0b3045f0e81a606d3a763
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B CCDC30 SAMD12 LGR4 ABTB2 DEPTOR OXR1 ABLIM1 NINL	1.53e-08	195	194	10	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO5B NAV2 AP1G2 CACNA1F OBSL1 LAMA3 GPAM HHIP EGFR P3H2	1.77e-08	198	194	10	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDGFA MYO5B NBEAL2 NAV2 CACNA1F LAMA3 HEATR5A PPL EGFR OSBPL3	1.85e-08	199	194	10	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRNP1 MYO5B NAV2 LAMA3 HEATR5A PPL EGFR P3H2 OSBPL3	9.65e-08	179	194	9	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 LGR4 MEST FAM135A DEPTOR OXR1 LAMA3 PPL OSBPL3	1.11e-07	182	194	9	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	MYO5B SAMD12 NBEAL2 NAV2 LAMA3 PPL ABLIM1 EGFR MICAL2	1.17e-07	183	194	9	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B LGR4 NAV2 FAM135A DEPTOR OXR1 LAMA3 PPL	1.40e-07	187	194	9	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B LGR4 NAV2 FAM135A DEPTOR OXR1 LAMA3 PPL	1.40e-07	187	194	9	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B LGR4 NAV2 FAM135A DEPTOR OXR1 LAMA3 PPL	1.40e-07	187	194	9	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 LGR4 ACTN4 NBEAL2 ABTB2 DEPTOR CPXM2 CYP27C1 OSBPL3	1.40e-07	187	194	9	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NAV2 DEPTOR LAMA3 HHIP TENM4 EGFR MICAL2 P3H2	1.47e-07	188	194	9	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDGFA MYO5B JADE1 NBEAL2 NAV2 LAMA3 PPL ABLIM1 P3H2	1.47e-07	188	194	9	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 LGR4 ACTN4 NBEAL2 ABTB2 DEPTOR CPXM2 CYP27C1 OSBPL3	1.53e-07	189	194	9	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BICDL2 ERBB4 MYO5B NBEAL2 NAV2 DEPTOR LAMA3 ABLIM1 P3H2	1.75e-07	192	194	9	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B CCDC30 SAMD12 KIF12 LGR4 OXR1 ABLIM1 NINL	1.83e-07	193	194	9	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 DEPTOR OXR1 LAMA3 PPL P3H2 HYDIN	1.91e-07	194	194	9	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERBB4 MYO5B SAMD12 NAV2 LAMA3 HHIP EGFR MICAL2 P3H2	1.91e-07	194	194	9	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 MYO5B SAMD12 LGR4 FAM135A ABTB2 OXR1 ABLIM1 NINL	1.91e-07	194	194	9	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	ERBB4 LGR4 NAV2 FAM135A DEPTOR OXR1 ABLIM1 TENM4 OSBPL3	2.09e-07	196	194	9	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRNP1 PDGFA MYO5B NAV2 AP1G2 CACNA1F LAMA3 HEATR5A OSBPL3	2.37e-07	199	194	9	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDGFA MYO5B NAV2 CACNA1F LAMA3 HEATR5A PPL EGFR OSBPL3	2.48e-07	200	194	9	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	Control\|World / group, cell type (main and fine annotations)	ERBB4 MYO5B SAMD12 NAV2 LAMA3 EGFR MICAL2 P3H2	7.63e-07	168	194	8	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	MYO5B SAMD12 NAV2 LAMA3 ABLIM1 EGFR MICAL2 P3H2	1.23e-06	179	194	8	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Ly6g5b+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICDL2 TRNP1 PODNL1 CISH NBEAL2 CXCR3 OSBPL3 LRRN4	1.28e-06	180	194	8	5c649e2b3f5a53c0040b69df6e289fb3427ef2db
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NAV2 CACNA1F LAMA3 HEATR5A PPL EGFR OSBPL3	1.34e-06	181	194	8	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASKIN2 SGSM3 ARHGEF37 PHLDB3 LAMA3 RGS3 CD93 CCDC171	1.34e-06	181	194	8	709e9c7a60d5f98635b99895ce30bb87a9f7376d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDGFA MYO5B SAMD12 NBEAL2 NAV2 LAMA3 ABLIM1 P3H2	1.51e-06	184	194	8	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	15-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	MYO5B LRRC26 RTTN HEATR5A CEP135 CEP83 CCDC171 CFAP46	1.57e-06	185	194	8	9a8b8360d99375b726ca8e3c9a3f9b08919892d7
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5B SAMD12 NBEAL2 NAV2 LAMA3 ABLIM1 NRBP2 EGFR	1.71e-06	187	194	8	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	COVID-19-kidney\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERBB4 MYO5B KIF12 LGR4 ABTB2 DEPTOR OXR1 P3H2	1.71e-06	187	194	8	d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell	LPS-IL1RA-Epithelial_alveolar\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NAV2 DEPTOR LAMA3 HHIP EGFR P3H2 VAMP8	1.78e-06	188	194	8	6164d467b612767ceba15de34176bcc8e8c36ab8
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ERBB4 MYO5B SAMD12 NAV2 LAMA3 EGFR MICAL2 P3H2	1.78e-06	188	194	8	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 NAV2 DEPTOR OXR1 OSBPL3 HYDIN	1.92e-06	190	194	8	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK4 MYO5B SAMD12 ACTN4 NBEAL2 NAV2 LAMA3 MICAL2	1.92e-06	190	194	8	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARHGEF11 LRRC26 C21orf58 RTTN CEP295 CCDC171 CFAP46 PCNT	1.92e-06	190	194	8	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TRNP1 ERBB4 SAMD12 NAV2 CARNS1 LAMA3 HHIP LRRN4	2.00e-06	191	194	8	4c4eb61e6179d2f8fc524d2f813db9cba84f67a2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 NAV2 DEPTOR OXR1 OSBPL3 PDE4DIP	2.00e-06	191	194	8	5a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 NAV2 DEPTOR OXR1 OSBPL3 PDE4DIP	2.00e-06	191	194	8	55ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCell	COVID-19-kidney-TAL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERBB4 LGR4 ABTB2 DEPTOR OXR1 TENM4 P3H2 OSBPL3	2.00e-06	191	194	8	fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ERBB4 MYO5B SAMD12 NAV2 LAMA3 EGFR MICAL2 P3H2	2.08e-06	192	194	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	ERBB4 MYO5B SAMD12 NAV2 LAMA3 EGFR MICAL2 P3H2	2.08e-06	192	194	8	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 DEPTOR OXR1 LAMA3 PPL P3H2	2.16e-06	193	194	8	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 DEPTOR OXR1 LAMA3 PPL P3H2	2.16e-06	193	194	8	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 LGR4 NAV2 DEPTOR CPXM2 OBSL1 ABLIM1 OSBPL3	2.33e-06	195	194	8	3123e02d2894c83962ba402085b5e6422ebf8c73
ToppCell	proximal-3-Hematologic-Natural_Killer_T\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	STMN3 BRD1 CXCR3 PSTPIP1 CCDC142 MIGA2 RPAP1 RASA4	2.33e-06	195	194	8	93093545bb23d2619ace029a52cffa1f673a0c2a
ToppCell	proximal-Hematologic-Natural_Killer_T-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	STMN3 BRD1 CXCR3 PSTPIP1 CCDC142 MIGA2 RPAP1 RASA4	2.33e-06	195	194	8	4d7c2c4d0130c2d46877ff6dd4584525d8f74daf
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERBB4 MYO5B SAMD12 NAV2 LAMA3 EGFR MICAL2 P3H2	2.33e-06	195	194	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	proximal-Hematologic-Natural_Killer_T\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	STMN3 BRD1 CXCR3 PSTPIP1 CCDC142 MIGA2 RPAP1 RASA4	2.33e-06	195	194	8	3944e4800f5d904d4efa401ce8913ec0e0781211
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 SAMD12 LGR4 ABTB2 OXR1 P3H2 OSBPL3 NINL	2.42e-06	196	194	8	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 LGR4 MEST NAV2 DEPTOR CPXM2 ABLIM1 OSBPL3	2.61e-06	198	194	8	688b0eb5534dde40b8630ab8a3252c816711e02e
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRNP1 PDGFA MYO5B NAV2 AP1G2 CACNA1F LAMA3 HEATR5A	2.61e-06	198	194	8	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	PDGFA MYO5B NBEAL2 NAV2 LAMA3 HEATR5A PPL VAMP8	2.61e-06	198	194	8	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 LGR4 MEST NAV2 DEPTOR OBSL1 ABLIM1 OSBPL3	2.61e-06	198	194	8	4448d13511485a44fe7b549e4b8b6ad7637db624
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB4 MYO5B SAMD12 LAMA3 HHIP EGFR MICAL2 P3H2	2.71e-06	199	194	8	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDGFA MYO5B NBEAL2 NAV2 CACNA1F LAMA3 HEATR5A VAMP8	2.81e-06	200	194	8	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DZIP1L C21orf58 RTTN CEP295 CCDC171 HYDIN CFAP46	5.87e-06	157	194	7	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KNTC1 ACTN4 TAOK2 MEST TEDC2 CD93 MAPK3	7.51e-06	163	194	7	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	KNTC1 ACTN3 CARNS1 RAG1 CPXM2 TRMT10A MMRN2	8.13e-06	165	194	7	a5c3af634d2698f9a01cf074791756b7669f9fff
ToppCell	droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF11 STMN3 KCTD7 PHLDB3 ANGPTL6 WDFY3 IL27	1.03e-05	171	194	7	e852d0e8589eecf4a2e5fea039b52a67c5d58dbd
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B OBSL1 LAMA3 HHIP TENM4 EGFR P3H2	1.38e-05	179	194	7	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMA3 HHIP TENM4 EGFR P3H2 VAMP8	1.48e-05	181	194	7	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 LGR4 MEST DEPTOR CYP27C1 KIF16B ABLIM1	1.48e-05	181	194	7	22363c5835dd6cef8f895ab9362e0837d92b15b1
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERBB4 KIF12 LGR4 ABTB2 DEPTOR OXR1 P3H2	1.54e-05	182	194	7	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 OBSL1 LAMA3 HHIP TENM4 EGFR P3H2	1.54e-05	182	194	7	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	ASK454-Epithelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	NAV2 CARNS1 ODAD3 LAMA3 PPL ABLIM1 HYDIN	1.54e-05	182	194	7	ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	ARHGEF11 SPTBN5 ELMOD3 HERC1 CCDC142 VPS13D	1.59e-05	122	194	6	1ed865f0ecfe304fb86313ff51c04e9052357270
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 DEPTOR LAMA3 ACAD10 HHIP P3H2 VAMP8	1.65e-05	184	194	7	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5B SAMD12 NAV2 LAMA3 ABLIM1 EGFR MICAL2	1.65e-05	184	194	7	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NAV2 LAMA3 PPL EGFR OSBPL3 VAMP8	1.65e-05	184	194	7	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-immature_innate_lymphoid_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BICDL2 PODNL1 CISH ANKRD35 CXCR3 OSBPL3 LRRN4	1.65e-05	184	194	7	3d8008f8d2e39c0d7a3cabc45620027491da03cf
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BICDL2 PODNL1 CISH ANKRD35 CXCR3 OSBPL3 LRRN4	1.65e-05	184	194	7	eeed75984ff111c0d1750df2f978163a42f20207
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5B SAMD12 NAV2 LAMA3 ABLIM1 EGFR MICAL2	1.65e-05	184	194	7	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5B SAMD12 NBEAL2 NAV2 LAMA3 ABLIM1 EGFR	1.71e-05	185	194	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Control-Epithelial_alveolar-AT_2-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DEPTOR OBSL1 LAMA3 ACAD10 HHIP P3H2 VAMP8	1.71e-05	185	194	7	8ca1374501eca01d8468130b74d50abfd4329fbe
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ERBB4 CCDC30 DZIP1L NWD1 CFAP44 HYDIN CFAP46	1.71e-05	185	194	7	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CASKIN2 TTC28 LAMA3 CD93 NINL MMRN2 EFCC1	1.77e-05	186	194	7	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 SAMD12 TAOK2 APC RGS3 CD93 MMRN2	1.77e-05	186	194	7	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	PDGFA MYO5B SAMD12 NBEAL2 NAV2 LAMA3 ABLIM1	1.77e-05	186	194	7	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	USP34 OXR1 KIF16B APC HEATR5A VPS13D CEP295	1.77e-05	186	194	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAV2 LAMA3 HHIP TENM4 EGFR MICAL2 P3H2	1.77e-05	186	194	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B NAV2 LAMA3 HHIP EGFR P3H2 VAMP8	1.83e-05	187	194	7	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	COVID-19-kidney-Mito-rich_Distal\|kidney / Disease (COVID-19 only), tissue and cell type	ERBB4 LGR4 NAV2 DEPTOR OXR1 TENM4 OSBPL3	1.83e-05	187	194	7	2ce8038d9d1302e850c1bb536e755598f77ba4b9
ToppCell	COVID-19-kidney-DCT\|kidney / Disease (COVID-19 only), tissue and cell type	ERBB4 LGR4 NAV2 DEPTOR CPXM2 ABLIM1 OSBPL3	1.89e-05	188	194	7	df1fd0819d301679f3c9ea404e942e39095912eb
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO5B NBEAL2 NAV2 FAM135A LAMA3 PPL MICAL2	1.89e-05	188	194	7	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ERBB4 PDGFA MYO5B KIF12 CPXM2 LAMA3 P3H2	1.89e-05	188	194	7	beb2df2332a46cc81b10e8e29fc9829020111f03
Drug	Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A	PDGFA CISH CASKIN2 NBEAL2 ZER1 ABHD14A LAMA3 ARVCF MICAL2 PDE4DIP CFAP44	8.66e-07	199	188	11	4799_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA	ZCCHC2 BMP5 SGSM3 RNF31 APC TAF6L RPAP1 MCM9 AQR PCNT	5.37e-06	195	188	10	989_DN
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	TTLL5 SLIT2 MVP ABTB2 ACAD10 DALRD3 ABLIM1 VPS13D RPAP1 MMRN2	5.62e-06	196	188	10	2888_DN
Drug	Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	DOCK4 PDGFA BRD1 DEPTOR TTC28 NLRX1 ACAD10 RGS3 VPS13D STAG3	5.88e-06	197	188	10	5514_DN
Drug	I50 - 9	ERBB4 EGFR MAPK3	3.01e-05	8	188	3	CID000083651
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A	USP34 CYP26A1 SGSM3 GPR27 NLRX1 APC GATC VPS13D AQR	3.12e-05	191	188	9	3888_DN
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	PSKH1 ULK1 SGSM3 ABTB2 TEDC2 INTS5 PDE4DIP MAPK3 CFAP44	3.53e-05	194	188	9	1226_DN
Drug	Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	TTLL5 CASKIN2 ULK1 DTX3 TEDC2 APC INTS5 EGFR STAG3	3.67e-05	195	188	9	2121_UP
Drug	Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A	PDGFA VWA8 BMP5 CASKIN2 NBEAL2 ZER1 DEPTOR KIF16B RPAP1	3.67e-05	195	188	9	6828_DN
Drug	Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ACTN4 BCL9 NAV2 SGSM3 ABHD14A DEPTOR TTC28 APC EGFR	3.82e-05	196	188	9	3271_DN
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A	PSKH1 BCL9 CASKIN2 ZER1 SGSM3 ABTB2 RNF31 NLRX1 ARHGAP45	3.82e-05	196	188	9	5079_DN
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A	PODNL1 BCL9 CASKIN2 AP1G2 DEPTOR TTC28 APC EGFR ARVCF	3.82e-05	196	188	9	2843_UP
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A	USP34 TTLL5 SLC35E1 AP1G2 ABHD14A TTC28 ABLIM1 INTS5 PDE4DIP	3.82e-05	196	188	9	3255_DN
Drug	15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	TTLL5 MVP GPR27 DTX3 NLRX1 APC RGS3 VPS13D ARHGAP45	3.98e-05	197	188	9	7521_UP
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	USP34 ARHGEF11 AP1G2 TTC28 APC LAMA3 TAF6L EGFR CEP135	3.98e-05	197	188	9	2262_DN
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	TAOK2 BMP5 SGSM3 APC RGS3 RPAP1 ARVCF PDE4DIP ARHGAP45	4.14e-05	198	188	9	3175_DN
Drug	Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	VWA8 BMP5 NBEAL2 AP1G2 SGSM3 BRD1 APC LAMA3 PDE4DIP	4.14e-05	198	188	9	6271_DN
Drug	Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A	USP9Y SPTBN5 BMP5 APC AIRE TAF6L ARVCF MICAL2 P3H2	4.14e-05	198	188	9	3904_UP
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	PDGFA BCL9 ARHGEF11 SGSM3 NLRX1 ACAD10 TAF6L MICAL2 PDE4DIP	4.14e-05	198	188	9	5524_DN
Drug	Iopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A	TTLL5 ARHGEF11 CISH ULK1 DEPTOR TEDC2 RGS3 VPS13D RPAP1	4.30e-05	199	188	9	5832_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	PDGFA SPTBN5 BMP5 ZER1 DEPTOR EGFR ARVCF MMRN2 STAG3	4.30e-05	199	188	9	6256_UP
Disease	Polyposis, Adenomatous Intestinal	CYP26A1 APC EGFR	1.28e-04	16	185	3	C2713442
Disease	Familial Intestinal Polyposis	CYP26A1 APC EGFR	1.28e-04	16	185	3	C2713443
Disease	Adenomatous Polyposis Coli	CYP26A1 APC EGFR	1.55e-04	17	185	3	C0032580
Disease	Animal Mammary Neoplasms	PDGFA ACTN4 APC GSS EGFR VAMP8	2.83e-04	142	185	6	C0024667
Disease	Mammary Carcinoma, Animal	PDGFA ACTN4 APC GSS EGFR VAMP8	2.83e-04	142	185	6	C1257925
Disease	Primary microcephaly	RTTN TRMT10A CEP135	3.42e-04	22	185	3	C0431350
Disease	focal segmental glomerulosclerosis 1 (implicated_via_orthology)	ACTN4 ACTN3	3.86e-04	5	185	2	DOID:0111128 (implicated_via_orthology)
Disease	sexual dimorphism measurement	BRPF3 GAPVD1 LGR4 TAOK2 SPTBN5 RNF214 PKD1 HERC1 CARNS1 APC CHSY1 GPAM GSS HHIP FER1L4 MAPK3 IL27	6.29e-04	1106	185	17	EFO_0021796
Disease	progressive familial intrahepatic cholestasis (is_implicated_in)	MYO5B KIF12	8.04e-04	7	185	2	DOID:0070221 (is_implicated_in)
Disease	Rectal Neoplasms	APC EGFR	8.04e-04	7	185	2	C0034885
Disease	Rectal Carcinoma	APC EGFR	8.04e-04	7	185	2	C0007113
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	GAPVD1 ACTN4 NUP205	8.69e-04	30	185	3	C1868672
Disease	platelet crit	PIEZO1 CYP26A1 ARHGEF11 NUP205 TFEC DEPTOR TTC28 RTTN KIF16B GPAM EGFR ARVCF P3H2 CHRD IL27	1.03e-03	952	185	15	EFO_0007985
Disease	NEPHRONOPHTHISIS 2	CEP83 TTC21B	1.07e-03	8	185	2	C1865872
Disease	carbohydrate intake measurement	HECTD4 ACAD10 CCDC171	1.26e-03	34	185	3	EFO_0010811
Disease	Autosomal Recessive Polycystic Kidney Disease	DZIP1L EGFR	1.37e-03	9	185	2	C0085548
Disease	Schizophrenia	DOCK4 ERBB4 MYO5B CHGA BCL9 ARHGEF11 BRD1 CACNA1F APC SLC1A6 TENM4 ARVCF MAPK3 PCNT	1.42e-03	883	185	14	C0036341
Disease	cystic kidney disease (implicated_via_orthology)	SLIT2 TTC21B	1.70e-03	10	185	2	DOID:2975 (implicated_via_orthology)
Disease	gallbladder neoplasm	ERBB4 EGFR	2.07e-03	11	185	2	C0016978
Disease	Malignant neoplasm of gallbladder	ERBB4 EGFR	2.07e-03	11	185	2	C0153452
Disease	Mesothelioma	PDGFA APC EGFR	2.17e-03	41	185	3	C0025500
Disease	progression free survival, urinary bladder cancer	ERBB4 TENM4	2.48e-03	12	185	2	EFO_0004920, MONDO_0001187
Disease	ascorbic acid 2-sulfate measurement	TAOK2 MAPK3	2.91e-03	13	185	2	EFO_0800169
Disease	Mammary Neoplasms, Experimental	PDGFA ACTN4 GSS EGFR VAMP8	3.01e-03	155	185	5	C0024668
Disease	mean fractional anisotropy measurement	PDGFA DEPTOR EGFR WDFY3	3.05e-03	95	185	4	EFO_0008399
Disease	Kartagener syndrome (implicated_via_orthology)	SLIT2 ODAD3	3.39e-03	14	185	2	DOID:0050144 (implicated_via_orthology)
Disease	median neuropathy (biomarker_via_orthology)	ERBB4 EGFR	3.39e-03	14	185	2	DOID:571 (biomarker_via_orthology)
Disease	diastolic blood pressure, systolic blood pressure	BRPF3 GAPVD1 CCDC30 FADD BCL9 BMP5 CHSY1 TENM4 ZIC5 CEP83 MMRN2	3.50e-03	670	185	11	EFO_0006335, EFO_0006336
Disease	Carcinomatosis	PDGFA ACTN4 GSS EGFR VAMP8	3.73e-03	163	185	5	C0205699
Disease	Carcinoma, Spindle-Cell	PDGFA ACTN4 GSS EGFR VAMP8	3.73e-03	163	185	5	C0205697
Disease	Undifferentiated carcinoma	PDGFA ACTN4 GSS EGFR VAMP8	3.73e-03	163	185	5	C0205698
Disease	Anaplastic carcinoma	PDGFA ACTN4 GSS EGFR VAMP8	3.73e-03	163	185	5	C0205696
Disease	ceramide measurement	TTLL5 OXR1 KIF16B MICAL2 CCDC171 ARHGAP45	3.77e-03	235	185	6	EFO_0010222
Disease	Carcinoma	PDGFA ACTN4 GSS EGFR VAMP8	3.82e-03	164	185	5	C0007097
Disease	2-hydroxyglutarate measurement	GAL3ST2 PCNT	4.43e-03	16	185	2	EFO_0021506
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	DZIP1L PKD1	4.43e-03	16	185	2	DOID:0110861 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	CYP26A1 IRAK1 C4orf50 ARHGEF11 NBEAL2 PKD1 NAV2 ZER1 ULK1 HECTD4 TENM4 LZTS2 CCDC171	5.22e-03	914	185	13	EFO_0004532
Disease	idiopathic pulmonary fibrosis	PSKH1 STMN3 DEPTOR	5.53e-03	57	185	3	EFO_0000768
Disease	Carcinoma, Granular Cell	CYP26A1 APC EGFR HRH4	6.21e-03	116	185	4	C0205644
Disease	Adenocarcinoma, Tubular	CYP26A1 APC EGFR HRH4	6.21e-03	116	185	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	CYP26A1 APC EGFR HRH4	6.21e-03	116	185	4	C0205642
Disease	Carcinoma, Cribriform	CYP26A1 APC EGFR HRH4	6.21e-03	116	185	4	C0205643
Disease	Adenocarcinoma, Basal Cell	CYP26A1 APC EGFR HRH4	6.21e-03	116	185	4	C0205641
Disease	Adenocarcinoma	CYP26A1 APC EGFR HRH4	6.21e-03	116	185	4	C0001418
Disease	primary ciliary dyskinesia (implicated_via_orthology)	SLIT2 ODAD3	6.23e-03	19	185	2	DOID:9562 (implicated_via_orthology)
Disease	esterified cholesterol measurement, high density lipoprotein cholesterol measurement	MYO5B OBSL1	6.23e-03	19	185	2	EFO_0004612, EFO_0008589
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB4 EGFR	6.23e-03	19	185	2	DOID:2876 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VERILARGENLEHLR	VAMP8	31	Q9BV40
RLSIFLELIDVHRLN	TTC21B	616	Q7Z4L5
HRRDLERILLTLGIR	CCAR2	721	Q8N163
AHILAVLLVSRGQRR	CXCR3	236	P49682
EDVERVQRLSLLLHL	FAM74A1	81	Q5RGS3
ERRLVHRDLAARNVL	ERBB4	836	Q15303
QRLRHDLERARLLIE	BRD1	526	O95696
EQLEHRLRTRLEREL	AMOT	621	Q4VCS5
HQRLREERDLVLTIA	ELMOD3	146	Q96FG2
RRIAELEIHLVVIQL	CYP27C1	491	Q4G0S4
LTRALEQERRHVALQ	ARVCF	26	O00192
HIEELLRNIRTQVLI	COPS2	346	P61201
ILREVDRTRLERHLA	ABLIM1	731	O14639
RARIRNLGSEVHLIE	ALS2	1611	Q96Q42
RSLLHQRLAVRELID	ARHGEF37	26	A1IGU5
QRLHAAEVERRSLRL	CCDC171	981	Q6TFL3
LLNEIRRLERLDHLA	ACTN4	401	O43707
HVQRVLAQLLRREAA	CD93	71	Q9NPY3
EASHLRTLRVLDLIF	ARHGEF11	746	O15085
LRLLRILGRNHEESS	AP1G2	251	O75843
QLRSVRQLEALARVH	CFAP46	1291	Q8IYW2
RQLEALARVHILLAL	CFAP46	1296	Q8IYW2
RETLQALHDRGLLRL	CARNS1	756	A5YM72
EIEQARLLVLRAAHL	ACAD10	966	Q6JQN1
RHDLERARLLIELIR	BRPF3	556	Q9ULD4
LRAVLLRLHREREQL	CCDC142	91	Q17RM4
EFLLELLVSRHERRI	AQR	401	O60306
LVDRHREAQQVLARL	ANKRD35	736	Q8N283
RSLQHLCRLVINRLV	CISH	221	Q9NSE2
HQRELSLLRKRLEEL	CEP83	671	Q9Y592
LVVTFDAELRLLRHQ	CFAP44	1376	Q96MT7
EEARQVVLRSLHRVR	EFCC1	286	Q9HA90
VVLRSLHRVRELEAL	EFCC1	291	Q9HA90
ALRRLLRLHRTEIAV	AIRE	6	O43918
LARNARIVHLVEETR	CPXM2	401	Q8N436
ERALARLERRHSALQ	KIF16B	1006	Q96L93
VRANHQVLTRLRELD	NWD1	271	Q149M9
TLFLLALRARNEHRQ	RAG1	436	P15918
RLLRVLQDLREAHSS	RASA4	771	O43374
RLLRVLQDLREAHSS	RASA4B	771	C9J798
LRLSIDAQDRVLLLH	RGS3	141	P49796
ILILAILREHRVDDS	MFSD8	226	Q8NHS3
RQRSHTQRLLHLLLD	NUP205	1131	Q92621
LDHILARESLRQLRH	ABHD14A	221	Q9BUJ0
IQTLRHLESLLRVQR	DZIP1L	481	Q8IYY4
RLHVRETELLFLRRL	OBSL1	1441	O75147
RGALQHRIRVLEEQL	PHLDB3	276	Q6NSJ2
RIKHLDVVALLRRIQ	CACNA1F	1476	O60840
HIQLALTLREELRSL	PSTPIP1	91	O43586
TLLLVLEDRLHRQLT	NRBP2	441	Q9NSY0
HLERIVEIARLRAVQ	KCTD7	166	Q96MP8
LQYLLRHLRRIVEVE	ARHGAP45	906	Q92619
LVALRVALREARATL	LZTS2	471	Q9BRK4
LIDEQSRRLGALRVH	MAGEE2	71	Q8TD90
RITAAVIEHLERLAL	GATC	31	O43716
DLSGREVELHLRLRI	LAMA3	936	Q16787
LLRVRASITLHERLR	IL17REL	26	Q6ZVW7
VQFLRRLDLSELLTH	HECA	341	Q9UBI9
ERRLELGQREHTQLL	LRSAM1	271	Q6UWE0
LVVVSFLHALRELRL	LRRIQ4	111	A6NIV6
LQVNHTALRELRVIL	MMRN2	436	Q9H8L6
RILAQQVHALERRLL	KIF12	451	Q96FN5
DLRALRALHLDSNRL	LRFN1	111	Q9P244
RLRLQDLLLEITAFH	FER1L4	81	A9Z1Z3
TTQAHLERLLQRVLR	GAPVD1	1226	Q14C86
VLAEATIQLIRILHR	HERC1	2211	Q15751
ESELRVLRRVRHANI	PSKH1	141	P11801
LRILLAQEHHTLRVR	FAM135A	331	Q9P2D6
NVLFALLIVRERSLH	GPR27	36	Q9NS67
HRRQLLEGELETLRR	PPL	1471	O60437
ERVQRLSLLLHLAVF	FAM74A3	116	Q4VXF1
RETLLRQHEAELLRV	JAKMIP3	91	Q5VZ66
RTLVNNLRELITLHR	KNTC1	686	P50748
LRILDLSRNLIHEIH	LGR4	391	Q9BXB1
VALALAAHQLKRRRR	MIGA2	56	Q7L4E1
LRRELEAQVHTIRIL	GOLGA6L1	121	Q8N7Z2
ALRRQLEAQDHTIRI	GOLGA6L7	81	A0A1B0GV03
ALRRELEAQVHTIRI	GOLGA6L22	71	H0YM25
LREIQILLRFRHENV	MAPK3	86	P27361
ILLRFRHENVIGIRD	MAPK3	91	P27361
RARVQRHLELLLRDL	NLRX1	926	Q86UT6
DLEAALRSHRRLREI	P3H2	66	Q8IVL5
ELLRLLQSGRRVHSV	OXA1L	11	Q15070
LAELLRTVHTLEQRR	HECTD4	2756	Q9Y4D8
ILTHLQLLRARDIIT	IRAK1	86	P51617
TIREEHRQALELLRA	PCNT	981	O95613
HREVIRQLLRAGIEI	CASKIN2	201	Q8WXE0
VRLRHADLEIRLAQD	MVP	81	Q14764
ERVQRLSLLLHLAVF	FAM74A7	116	A6NL05
LHTARARAIEALVEL	MYO15B	1401	Q96JP2
RELSLAHNRLRVGDI	PODNL1	456	Q6PEZ8
HRRIDALNTEELRTL	OXR1	661	Q8N573
LLSIDTERRHLRERV	CEP135	911	Q66GS9
LQALHRLTRLVAFRD	COMMD9	61	Q9P000
EVERRFRLVLIAEHL	GAL3ST2	216	Q9H3Q3
IAEHLDESLVLLRRR	GAL3ST2	226	Q9H3Q3
RLARLREEHRVSILI	DTX3	36	Q8N9I9
RRLVHRDLAARNVLV	EGFR	831	P00533
RERNRLITHLLQELH	C4orf50	86	Q6ZRC1
LHFDRLLLHRQESRV	HYDIN	2941	Q4G0P3
LLLHRQESRVVLLRN	HYDIN	2946	Q4G0P3
VSDLNDLRRVHQLLV	HEATR5A	1351	Q86XA9
EILDLRRQVLVGHLT	DOCK4	121	Q8N1I0
LVVTCLERRHRLQVL	GCNT7	391	Q6ZNI0
RLREQHLLDELSRAQ	C21orf58	146	P58505
EVLALIFRHLSLRDR	FBXL8	11	Q96CD0
QLRHLDLRRLSFTLD	FBXL8	136	Q96CD0
LEHRERSLQTLRDIQ	BCL9	356	O00512
LRILAHLSHDRRLIQ	POLQ	2336	O75417
AEVLVTGEQLRLRLH	DEPTOR	31	Q8TB45
ELLRELLASLRRHDL	FADD	61	Q13158
LLASLRRHDLLRRVD	FADD	66	Q13158
LLHSLELVLSRAVRE	IL27	206	Q8NEV9
LLRAHVALLRIRQGD	GPAT2	511	Q6NUI2
HRERSLQTLRDIERL	BCL9L	406	Q86UU0
VRLREELSHINQSLL	CCDC30	196	Q5VVM6
RHEELLRELQRLAAA	ANGPTL6	71	Q8NI99
LLVLLRHLVQERANA	ANGPT4	261	Q9Y264
LEHVLRFLRRNAFIL	SLC1A6	46	P48664
HERREIQREILSILG	BMP5	46	P22003
EGRLQTTHEELLLLR	BICDL2	231	A1A5D9
TTHEELLLLRRERRE	BICDL2	236	A1A5D9
LLLLRRERREHSLEL	BICDL2	241	A1A5D9
QLRTVLVADHLARAL	DALRD3	136	Q5D0E6
VRLQLLRAVREVLHT	DALRD3	516	Q5D0E6
NVRRILLGEHRLVSV	CYP26A1	96	O43174
VLLSRRTNLLAALHR	DCST2	546	Q5T1A1
RETLGLLRQIITDHR	EIF2B2	36	P49770
ELLARNIHVIRRTFE	GSS	226	P48637
ILARQEAREELLLHQ	CEP295	1366	Q9C0D2
IVEALLRHLGLQNRR	MEST	126	Q5EB52
LQVLTLRHNRIAALR	LRRN4	101	Q8WUT4
ALVRERQAHQLLVAL	MICAL2	381	O94851
ERLRRIHAESLLLDS	OSBPL3	396	Q9H4L5
SLEESRDRLRFLQLH	PKD1	3826	P98161
IHARFIRAVSELELL	ORC3	676	Q9UBD5
EARRLQALHEAILSI	OSBPL5	811	Q9H0X9
IRLLESLIRLAEAHA	MCM9	566	Q9NXL9
ALHQREHVELLRARR	HRH4	286	Q9H3N8
QRQVLDEALLRRLHL	RPUSD3	286	Q6P087
LIRKLGHQLAEIRER	RTTN	6	Q86VV8
EQLHRLLQVARSLFR	TAF6L	211	Q9Y6J9
HRRLDEEQQVLLSRL	TRIM39	201	Q9HCM9
ELLQRLLHRAFVVET	STAT2	306	P52630
LVLVIARVRRLHNVT	PRLHR	81	P49683
LQLEQSLRVCRRLLH	TEDC2	26	Q7L2K0
IITEVHLRRRNVQFL	NKPD1	41	Q17RQ9
RRLEELQLQHSLRLL	ODAD3	176	A5D8V7
VHLRRFNLRRSALEL	NBEAL2	1976	Q6ZNJ1
RRRLIANLAEHILFT	GPAM	461	Q9HCL2
SAHLVVLIALERRRA	GPR150	136	Q8NGU9
QRYVSLLIEHRRIIL	NAV2	2141	Q8IVL1
LVADLREAILRVARH	SGSM3	431	Q96HU1
LRQHEATRELELRQL	TAOK2	681	Q9UL54
VRENLLLFLHRISII	SAMD12	181	Q8N8I0
VHLQLLRRHTLRAAE	STARD9	746	Q9P2P6
VREACDRLIQLLLLH	INTS5	431	Q6P9B9
LFTHLRQDLERVRNL	JADE1	491	Q6IE81
VLRDSRIHHLRLLNI	SLC35E1	211	Q96K37
ELHRLLSLQGEQARR	NINL	1261	Q9Y2I6
LRTARVFLEVAELHR	HHIP	336	Q96QV1
DQAAAETLLRRHVRL	SPTBN5	776	Q9NRC6
IREAHLAALRERLRE	STMN3	146	Q9NZ72
LIRVAREAQRLSVLH	ABTB2	136	Q8N961
LLSEIRRLQRLQHLA	ACTN3	396	Q08043
RREIRVLHLLEQIRA	APC	401	P25054
RGDERILSILRHQNL	CHGA	61	P10645
ELRHRTIQLHREIVL	CHSY1	326	Q86X52
LRLLRAEQLHVALVT	CHRD	246	Q9H2X0
QRVTLREHLERLRAA	ZCCHC2	276	Q9C0B9
AVRHSQDRAFLRRLL	RNF31	681	Q96EP0
LILILRALHVNNDRA	PRPF8	1936	Q6P2Q9
LIQLVAARLAEHERV	RNF214	596	Q8ND24
ELHVRLERRSRLVVL	URGCP	681	Q8TCY9
LERLERVRNLHIREL	TLK1	421	Q9UKI8
RLTRIHLREDLVQDQ	ZER1	81	Q7Z7L7
DILRALLSVLRESHR	WDFY3	626	Q8IZQ1
SLGRVLHRRILEEAQ	TRPM5	141	Q9NZQ8
SQIHSIRDLQRLLEI	PDGFA	36	P04085
IVREIFSLVLRRQAH	SLC37A3	476	Q8NCC5
HLQIERLHQRRRLLA	STAG3	861	Q9UJ98
EHRLVSLITLLRDAI	SNX14	841	Q9Y5W7
RAALNEIESRHRELL	STX11	201	O75558
RLESRIRDVHELFLQ	STX11	216	O75558
QRLQLLLRHISRESI	TRAV16	61	A0A0A6YYK6
LRVHNRNLLSLDFDR	TENM4	1831	Q6N022
DLKELERLRLNRNHL	SLIT2	101	O94813
LLERQIIIEANDRHL	VIPAS39	296	Q9H9C1
HLLRATLNLLRREVS	USP9Y	2156	O00507
VVLDILAVLIRLARH	RPAP1	561	Q9BWH6
QVVERLLQHLRRVDA	TXNDC11	411	Q6PKC3
ERARDALRVLLHLVE	TTC28	1736	Q96AY4
RGLVHLILIRSNERE	TRAV17	61	A0A0B4J275
LLLRIQELEIQARTH	TFEC	216	O14948
RVRRDVVHSTLRLII	TRMT10A	91	Q8TBZ6
RVQVFLRRLLELHVF	PIEZO1	801	Q92508
LARHLADCIRSREIL	USP34	1761	Q70CQ2
AVRRQVHSLRIILDN	VWA8	1646	A3KMH1
RVLQLHRVFLAAELR	TRNP1	126	Q6NT89
RLLDRIHSITAERLI	ULK1	966	O75385
LLERRRILAHQLGDF	TTLL5	741	Q6EMB2
SQLRAAVAHLRLRDL	ZIC5	66	Q96T25
VAVEIHRLNLLLLRT	VPS13D	1166	Q5THJ4
LRLRALLLDHNRVRA	LRRC26	71	Q2I0M4
LAEHLRRIRAAVVLQ	MYO5B	806	Q9ULV0
LRQLRLAVRERDHDL	PDE4DIP	506	Q5VU43